
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.45 | 0.45 | 0.00 |
Shares | 99.55 | 99.55 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.88 | 18.84 |
Price to Book | 3.49 | 4.28 |
Price to Sales | 2.51 | 2.30 |
Price to Cash Flow | 14.28 | 15.61 |
Dividend Yield | 1.66 | 1.18 |
5 Years Earnings Growth | 14.78 | 11.02 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 96.63 | 99.59 |
Financial Services | 1.92 | 0.73 |
Communication Services | 0.69 | 0.65 |
Consumer Defensive | 0.60 | 0.48 |
Basic Materials | 0.12 | 1.02 |
Technology | 0.04 | 0.17 |
Number of long holdings: 110
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.50 | 762.33 | +3.01% | |
Boston Scientific | US1011371077 | 5.35 | 105.41 | +0.47% | |
UnitedHealth | US91324P1021 | 4.90 | 237.77 | -4.72% | |
Regeneron Pharma | US75886F1075 | 4.46 | 558.87 | +2.46% | |
Merck&Co | US58933Y1055 | 4.17 | 79.29 | +1.50% | |
Pfizer | US7170811035 | 4.11 | 23.49 | +0.86% | |
Chugai Pharmaceutical | JP3519400000 | 3.96 | 7,317.0 | -0.31% | |
AbbVie | US00287Y1091 | 3.69 | 195.22 | +3.28% | |
Amgen | US0311621009 | 3.66 | 296.88 | +0.60% | |
Roche Holding Participation | CH0012032048 | 3.62 | 257.10 | -0.96% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Delaware Small Cap Core I | 4.74B | -3.72 | 8.03 | 7.66 | ||
Delaware Emerging Markets Instl | 3.1B | 30.80 | 15.69 | 7.85 | ||
Delaware Small Cap Value Instl | 1.82B | -0.26 | 8.70 | 7.31 | ||
Optimum Large Cap Growth Instl | 1.95B | 4.30 | 24.24 | 13.46 | ||
Optimum Large Cap Value Instl | 1.82B | 6.20 | 12.74 | 8.86 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review